0 XP   0   0   0

Lincoln Pharmaceuticals Limited
Buy, Hold or Sell?

Should you buy, hold or sell Lincoln Pharmaceuticals Limited?

I guess you are interested in Lincoln Pharmaceuticals Limited. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse Lincoln Pharmaceuticals Limited

Let's start. I'm going to help you getting a better view of Lincoln Pharmaceuticals Limited. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is Lincoln Pharmaceuticals Limited even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how Lincoln Pharmaceuticals Limited is doing in the market. If the company is worth buying. The latest step is to find out how other investors value Lincoln Pharmaceuticals Limited. The closing price on 2023-01-25 was INR318.55 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
Lincoln Pharmaceuticals Limited Daily Candlestick Chart
Lincoln Pharmaceuticals Limited Daily Candlestick Chart
Summary









1. Valuation of Lincoln Pharmaceuticals Limited




Current price per share

INR318.55

2. Growth of Lincoln Pharmaceuticals Limited




Is Lincoln Pharmaceuticals Limited growing?

Current yearPrevious yearGrowGrow %
How rich?$53.2m$46.1m$7m13.3%

How much money is Lincoln Pharmaceuticals Limited making?

Current yearPrevious yearGrowGrow %
Making money$8.5m$7.6m$877.1k10.3%
Net Profit Margin14.7%14.7%--

How much money comes from the company's main activities?

3. Financial Health of Lincoln Pharmaceuticals Limited




Comparing to competitors in the Drug Manufacturers - Major industry




  Industry Rankings (Drug Manufacturers - Major)  


Richest
#10 / 12

Most Revenue
#10 / 12


Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is very efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

1.1. Profitability of Lincoln Pharmaceuticals Limited.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Lincoln Pharmaceuticals Limited earns for each ₹1 of revenue.

  • Above 10% is considered healthy but always compare Lincoln Pharmaceuticals Limited to the Drug Manufacturers - Major industry mean.
  • A Net Profit Margin of 14.7% means that ₹0.15 for each ₹1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Lincoln Pharmaceuticals Limited:

  • The MRQ is 14.7%. The company is making a huge profit. +2
  • The TTM is 14.7%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ14.7%TTM14.7%0.0%
TTM14.7%YOY14.7%+0.0%
TTM14.7%5Y13.1%+1.6%
5Y13.1%10Y10.0%+3.1%
Compared to industry (Drug Manufacturers - Major)
PeriodCompanyIndustry (mean)+/- 
MRQ14.7%10.8%+3.9%
TTM14.7%10.8%+3.9%
YOY14.7%14.8%-0.1%
5Y13.1%12.2%+0.9%
10Y10.0%11.9%-1.9%
1.1.2. Return on Assets

Shows how efficient Lincoln Pharmaceuticals Limited is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Lincoln Pharmaceuticals Limited to the Drug Manufacturers - Major industry mean.
  • 13.0% Return on Assets means that Lincoln Pharmaceuticals Limited generated ₹0.13 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Lincoln Pharmaceuticals Limited:

  • The MRQ is 13.0%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 13.0%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ13.0%TTM13.0%0.0%
TTM13.0%YOY13.5%-0.6%
TTM13.0%5Y12.6%+0.4%
5Y12.6%10Y10.1%+2.5%
Compared to industry (Drug Manufacturers - Major)
PeriodCompanyIndustry (mean)+/- 
MRQ13.0%1.8%+11.2%
TTM13.0%2.3%+10.7%
YOY13.5%3.0%+10.5%
5Y12.6%3.0%+9.6%
10Y10.1%2.7%+7.4%
1.1.3. Return on Equity

Shows how efficient Lincoln Pharmaceuticals Limited is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Lincoln Pharmaceuticals Limited to the Drug Manufacturers - Major industry mean.
  • 16.0% Return on Equity means Lincoln Pharmaceuticals Limited generated ₹0.16 for each ₹1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Lincoln Pharmaceuticals Limited:

  • The MRQ is 16.0%. Using its investors money, the company is efficient in making profit. +1
  • The TTM is 16.0%. Using its investors money, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ16.0%TTM16.0%0.0%
TTM16.0%YOY16.6%-0.6%
TTM16.0%5Y16.5%-0.5%
5Y16.5%10Y15.3%+1.2%
Compared to industry (Drug Manufacturers - Major)
PeriodCompanyIndustry (mean)+/- 
MRQ16.0%2.5%+13.5%
TTM16.0%3.9%+12.1%
YOY16.6%4.4%+12.2%
5Y16.5%4.2%+12.3%
10Y15.3%4.0%+11.3%

1.2. Operating Efficiency of Lincoln Pharmaceuticals Limited.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Lincoln Pharmaceuticals Limited is operating .

  • Measures how much profit Lincoln Pharmaceuticals Limited makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Lincoln Pharmaceuticals Limited to the Drug Manufacturers - Major industry mean.
  • An Operating Margin of 0.0% means the company generated ₹0.00  for each ₹1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Lincoln Pharmaceuticals Limited:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y11.0%-11.0%
5Y11.0%10Y10.2%+0.8%
Compared to industry (Drug Manufacturers - Major)
PeriodCompanyIndustry (mean)+/- 
MRQ-29.7%-29.7%
TTM-11.5%-11.5%
YOY-11.7%-11.7%
5Y11.0%12.0%-1.0%
10Y10.2%11.0%-0.8%
1.2.2. Operating Ratio

Measures how efficient Lincoln Pharmaceuticals Limited is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Major industry mean).
  • An Operation Ratio of 0.46 means that the operating costs are ₹0.46 for each ₹1 in net sales.

Let's take a look of the Operating Ratio trends of Lincoln Pharmaceuticals Limited:

  • The MRQ is 0.463. The company is very efficient in keeping operating costs low. +2
  • The TTM is 0.463. The company is very efficient in keeping operating costs low. +2
Trends
Current periodCompared to+/- 
MRQ0.463TTM0.4630.000
TTM0.463YOY0.487-0.024
TTM0.4635Y0.987-0.524
5Y0.98710Y1.248-0.261
Compared to industry (Drug Manufacturers - Major)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4630.475-0.012
TTM0.4630.425+0.038
YOY0.4870.731-0.244
5Y0.9870.943+0.044
10Y1.2480.983+0.265

1.3. Liquidity of Lincoln Pharmaceuticals Limited.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Lincoln Pharmaceuticals Limited is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Major industry mean).
  • A Current Ratio of 3.90 means the company has ₹3.90 in assets for each ₹1 in short-term debts.

Let's take a look of the Current Ratio trends of Lincoln Pharmaceuticals Limited:

  • The MRQ is 3.899. The company is very able to pay all its short-term debts. +2
  • The TTM is 3.899. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ3.899TTM3.8990.000
TTM3.899YOY4.167-0.267
TTM3.8995Y3.311+0.589
5Y3.31110Y2.522+0.789
Compared to industry (Drug Manufacturers - Major)
PeriodCompanyIndustry (mean)+/- 
MRQ3.8991.824+2.075
TTM3.8991.800+2.099
YOY4.1671.807+2.360
5Y3.3111.305+2.006
10Y2.5221.218+1.304
1.3.2. Quick Ratio

Measures if Lincoln Pharmaceuticals Limited is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Lincoln Pharmaceuticals Limited to the Drug Manufacturers - Major industry mean.
  • A Quick Ratio of 3.65 means the company can pay off ₹3.65 for each ₹1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Lincoln Pharmaceuticals Limited:

  • The MRQ is 3.647. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 3.647. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ3.647TTM3.6470.000
TTM3.647YOY3.865-0.218
TTM3.6475Y2.696+0.951
5Y2.69610Y1.960+0.735
Compared to industry (Drug Manufacturers - Major)
PeriodCompanyIndustry (mean)+/- 
MRQ3.6471.248+2.399
TTM3.6471.200+2.447
YOY3.8651.151+2.714
5Y2.6960.836+1.860
10Y1.9600.750+1.210

1.4. Solvency of Lincoln Pharmaceuticals Limited.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Lincoln Pharmaceuticals Limited assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Lincoln Pharmaceuticals Limited to Drug Manufacturers - Major industry mean.
  • A Debt to Asset Ratio of 0.19 means that Lincoln Pharmaceuticals Limited assets are financed with 19.0% credit (debt) and the remaining percentage (100% - 19.0%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Lincoln Pharmaceuticals Limited:

  • The MRQ is 0.190. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.190. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.190TTM0.1900.000
TTM0.190YOY0.183+0.007
TTM0.1905Y0.237-0.048
5Y0.23710Y0.355-0.118
Compared to industry (Drug Manufacturers - Major)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1900.415-0.225
TTM0.1900.419-0.229
YOY0.1830.429-0.246
5Y0.2370.455-0.218
10Y0.3550.431-0.076
1.4.2. Debt to Equity Ratio

Measures if Lincoln Pharmaceuticals Limited is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Lincoln Pharmaceuticals Limited to the Drug Manufacturers - Major industry mean.
  • A Debt to Equity ratio of 23.4% means that company has ₹0.23 debt for each ₹1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Lincoln Pharmaceuticals Limited:

  • The MRQ is 0.234. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.234. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.234TTM0.2340.000
TTM0.234YOY0.224+0.010
TTM0.2345Y0.322-0.087
5Y0.32210Y0.667-0.345
Compared to industry (Drug Manufacturers - Major)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2340.675-0.441
TTM0.2340.698-0.464
YOY0.2240.738-0.514
5Y0.3220.840-0.518
10Y0.6670.814-0.147

2. Market Valuation of Lincoln Pharmaceuticals Limited

2. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₹1 in earnings Lincoln Pharmaceuticals Limited generates.

  • Above 15 is considered overpriced but always compare Lincoln Pharmaceuticals Limited to the Drug Manufacturers - Major industry mean.
  • A PE ratio of 8.98 means the investor is paying ₹8.98 for every ₹1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Lincoln Pharmaceuticals Limited:

  • The EOD is 9.200. Very good. +2
  • The MRQ is 8.983. Very good. +2
  • The TTM is 8.983. Very good. +2
Trends
Current periodCompared to+/- 
EOD9.200MRQ8.983+0.217
MRQ8.983TTM8.9830.000
TTM8.983YOY7.222+1.761
TTM8.9835Y8.457+0.527
5Y8.45710Y10.068-1.611
Compared to industry (Drug Manufacturers - Major)
PeriodCompanyIndustry (mean)+/- 
EOD9.20073.229-64.029
MRQ8.98366.328-57.345
TTM8.98360.797-51.814
YOY7.22233.289-26.067
5Y8.45760.412-51.955
10Y10.06864.422-54.354
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of Lincoln Pharmaceuticals Limited.

  • Lower is better.
  • A PEG ratio of 1 means the market price of the stock and the expected future earnings are on par.

Let's take a look of the Price Earnings to Growth Ratio trends of Lincoln Pharmaceuticals Limited:

  • The MRQ is 8.071. Seems overpriced? -1
  • The TTM is 8.071. Seems overpriced? -1
Trends
Current periodCompared to+/- 
MRQ8.071TTM8.0710.000
TTM8.071YOY5.971+2.101
TTM8.0715Y7.008+1.064
5Y7.00810Y8.125-1.117
Compared to industry (Drug Manufacturers - Major)
PeriodCompanyIndustry (mean)+/- 
MRQ8.071-0.235+8.306
TTM8.0710.137+7.934
YOY5.9710.124+5.847
5Y7.0080.232+6.776
10Y8.1250.222+7.903

2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Lincoln Pharmaceuticals Limited is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers - Major industry mean).
  • A PB ratio of 1.44 means the investor is paying ₹1.44 for each ₹1 in book value.

Let's take a look of the Price to Book Ratio trends of Lincoln Pharmaceuticals Limited:

  • The EOD is 1.474. Good. +1
  • The MRQ is 1.439. Good. +1
  • The TTM is 1.439. Good. +1
Trends
Current periodCompared to+/- 
EOD1.474MRQ1.439+0.035
MRQ1.439TTM1.4390.000
TTM1.439YOY1.197+0.242
TTM1.4395Y1.389+0.050
5Y1.38910Y1.530-0.141
Compared to industry (Drug Manufacturers - Major)
PeriodCompanyIndustry (mean)+/- 
EOD1.4741.495-0.021
MRQ1.4391.439+0.000
TTM1.4391.890-0.451
YOY1.1972.460-1.263
5Y1.3891.972-0.583
10Y1.5302.221-0.691
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Lincoln Pharmaceuticals Limited compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--28.47228.4720%31.102-8%23.985+19%24.013+19%
Book Value Growth--1.1531.1530%1.199-4%1.176-2%1.199-4%
Book Value Per Share--216.118216.1180%187.646+15%161.418+34%120.383+80%
Book Value Per Share Growth--1.1521.1520%1.199-4%1.176-2%1.199-4%
Current Ratio--3.8993.8990%4.167-6%3.311+18%2.522+55%
Debt To Asset Ratio--0.1900.1900%0.183+4%0.237-20%0.355-47%
Debt To Equity Ratio--0.2340.2340%0.224+5%0.322-27%0.667-65%
Dividend Per Share--1.4981.4980%-+100%1.672-10%1.274+18%
Eps--34.62634.6260%31.112+11%26.625+30%19.096+81%
Eps Growth--1.1131.1130%1.210-8%1.203-8%1.274-13%
Free Cash Flow Per Share--15.28115.2810%30.260-50%21.344-28%14.071+9%
Free Cash Flow Per Share Growth--0.5050.5050%0.894-43%1.541-67%4.685-89%
Free Cash Flow To Equity Per Share--14.00514.0050%27.387-49%12.021+16%6.355+120%
Free Cash Flow To Equity Per Share Growth--0.5110.5110%1.828-72%3.488-85%2.745-81%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--178.514--------
Intrinsic Value_10Y_min--152.173--------
Intrinsic Value_1Y_max--15.879--------
Intrinsic Value_1Y_min--15.429--------
Intrinsic Value_3Y_max--49.240--------
Intrinsic Value_3Y_min--46.477--------
Intrinsic Value_5Y_max--84.449--------
Intrinsic Value_5Y_min--77.416--------
Net Profit Margin--0.1470.1470%0.147+0%0.131+12%0.100+47%
Operating Margin----0%-0%0.110-100%0.102-100%
Operating Ratio--0.4630.4630%0.487-5%0.987-53%1.248-63%
Pb Ratio1.474+2%1.4391.4390%1.197+20%1.389+4%1.530-6%
Pe Ratio9.200+2%8.9838.9830%7.222+24%8.457+6%10.068-11%
Peg Ratio--8.0718.0710%5.971+35%7.008+15%8.125-1%
Price Per Share318.550+2%311.050311.0500%224.700+38%218.480+42%178.406+74%
Price To Total Gains Ratio10.629+2%10.37910.3790%7.225+44%8.738+19%8.447+23%
Profit Growth--1.1151.1150%1.210-8%1.204-7%1.274-13%
Quick Ratio--3.6473.6470%3.865-6%2.696+35%1.960+86%
Return On Assets--0.1300.1300%0.135-4%0.126+3%0.101+29%
Return On Equity--0.1600.1600%0.166-3%0.165-3%0.153+5%
Revenue Growth--1.1131.1130%1.098+1%1.054+6%1.1190%
Total Gains Per Share--29.97029.9700%31.102-4%25.657+17%25.287+19%
Total Gains Per Share Growth--0.9640.9640%1.220-21%1.064-9%1.187-19%
Usd Book Value--53243932.50053243932.5000%46160916.000+15%39724595.395+34%29622995.340+80%
Usd Book Value Change Per Share--0.3500.3500%0.383-8%0.295+19%0.295+19%
Usd Book Value Per Share--2.6582.6580%2.308+15%1.985+34%1.481+80%
Usd Dividend Per Share--0.0180.0180%-+100%0.021-10%0.016+18%
Usd Eps--0.4260.4260%0.383+11%0.327+30%0.235+81%
Usd Free Cash Flow----0%-0%-0%-0%
Usd Free Cash Flow Per Share--0.1880.1880%0.372-50%0.263-28%0.173+9%
Usd Free Cash Flow To Equity Per Share--0.1720.1720%0.337-49%0.148+16%0.078+120%
Usd Price Per Share3.918+2%3.8263.8260%2.764+38%2.687+42%2.194+74%
Usd Profit--8530701.9008530701.9000%7653502.800+11%6552237.503+30%4698914.686+82%
Usd Revenue--58071165.90058071165.9000%52174816.500+11%49461188.015+17%44455825.172+31%
Usd Total Gains Per Share--0.3690.3690%0.383-4%0.316+17%0.311+19%
 EOD+2 -3MRQTTM+0 -0YOY+14 -255Y+23 -1710Y+30 -10

3.2. Fundamental Score

Let's check the fundamental score of Lincoln Pharmaceuticals Limited based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-159.200
Price to Book Ratio (EOD)Between0-11.474
Net Profit Margin (MRQ)Greater than00.147
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than13.647
Current Ratio (MRQ)Greater than13.899
Debt to Asset Ratio (MRQ)Less than10.190
Debt to Equity Ratio (MRQ)Less than10.234
Return on Equity (MRQ)Greater than0.150.160
Return on Assets (MRQ)Greater than0.050.130
Total8/10 (80.0%)

3.3. Technical Score

Let's check the technical score of Lincoln Pharmaceuticals Limited based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose327.750
Total1/1 (100.0%)



Latest Balance Sheet

Balance Sheet of 2022-03-31. Currency in INR. All numbers in thousands.

Summary
Total Assets5,343,574
Total Liabilities1,014,799
Total Stockholder Equity4,328,775
 As reported
Total Liabilities 1,014,799
Total Stockholder Equity+ 4,328,775
Total Assets = 5,343,574

Assets

Total Assets5,343,574
Total Current Assets3,528,495
Long-term Assets3,528,495
Total Current Assets
Cash And Cash Equivalents 69,341
Short-term Investments 976,296
Net Receivables 1,159,414
Inventory 727,420
Other Current Assets 159,597
Total Current Assets  (as reported)3,528,495
Total Current Assets  (calculated)3,092,068
+/- 436,427
Long-term Assets
Property Plant Equipment 1,475,518
Intangible Assets 3,827
Long-term Assets  (as reported)0
Long-term Assets  (calculated)1,479,345
+/- 1,479,345

Liabilities & Shareholders' Equity

Total Current Liabilities904,862
Long-term Liabilities-
Total Stockholder Equity4,328,775
Total Current Liabilities
Short-term Debt 20,436
Total Current Liabilities  (as reported)904,862
Total Current Liabilities  (calculated)20,436
+/- 884,426
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/-0
Total Stockholder Equity
Common Stock200,297
Retained Earnings 4,128,478
Total Stockholder Equity (as reported)4,328,775
Total Stockholder Equity (calculated)4,328,775
+/-0
Other
Cash And Equivalents118,654
Cash and Short Term Investments 1,164,291
Common Stock Shares Outstanding 20,030
Liabilities and Stockholders Equity 5,343,574



Balance Sheet

Currency in INR. All numbers in thousands.

 Trend2022-03-312021-03-312020-03-312019-03-312018-03-312017-03-312016-03-312015-03-312014-03-31
> Total Assets 
2,597,555
2,580,285
2,757,221
3,053,394
3,472,351
3,659,849
3,893,878
4,593,717
5,343,574
5,343,5744,593,7173,893,8783,659,8493,472,3513,053,3942,757,2212,580,2852,597,555
   > Total Current Assets 
1,490,630
1,773,856
1,476,552
1,810,494
2,183,362
2,240,422
2,479,971
3,064,559
3,528,495
3,528,4953,064,5592,479,9712,240,4222,183,3621,810,4941,476,5521,773,8561,490,630
       Cash And Cash Equivalents 
104,514
115,094
92,299
85,612
80,194
21,197
23,509
114,384
69,341
69,341114,38423,50921,19780,19485,61292,299115,094104,514
       Short-term Investments 
0
0
0
102,000
171,115
181,009
181,009
807,478
976,296
976,296807,478181,009181,009171,115102,000000
       Net Receivables 
1,020,763
1,264,118
797,597
906,695
1,094,408
1,224,694
1,013,359
1,113,275
1,159,414
1,159,4141,113,2751,013,3591,224,6941,094,408906,695797,5971,264,1181,020,763
       Inventory 
238,410
218,184
274,819
373,060
454,115
362,257
473,960
466,127
727,420
727,420466,127473,960362,257454,115373,060274,819218,184238,410
       Other Current Assets 
126,943
176,460
268,323
300,610
378,874
345,233
344,456
200,803
159,597
159,597200,803344,456345,233378,874300,610268,323176,460126,943
   > Long-term Assets 
0
0
0
1,283,080
1,288,989
1,444,394
1,419,427
0
0
001,419,4271,444,3941,288,9891,283,080000
       Property Plant Equipment 
627,959
628,854
913,388
997,413
1,073,055
1,133,529
1,131,656
1,119,260
1,475,518
1,475,5181,119,2601,131,6561,133,5291,073,055997,413913,388628,854627,959
       Goodwill 
41,430
48,006
92,256
92,256
92,256
92,256
92,256
92,256
0
092,25692,25692,25692,25692,25692,25648,00641,430
       Long Term Investments 
4,057
55
55
55
0
0
0
0
0
000005555554,057
       Intangible Assets 
5,060
4,814
2,557
3,749
3,355
4,241
3,694
3,981
3,827
3,8273,9813,6944,2413,3553,7492,5574,8145,060
> Total Liabilities 
1,572,377
1,437,910
1,321,470
1,129,545
1,230,171
966,403
762,989
840,797
1,014,799
1,014,799840,797762,989966,4031,230,1711,129,5451,321,4701,437,9101,572,377
   > Total Current Liabilities 
1,310,531
1,106,528
1,047,687
908,869
1,049,348
853,362
655,826
735,455
904,862
904,862735,455655,826853,3621,049,348908,8691,047,6871,106,5281,310,531
       Short-term Debt 
681,365
764,840
524,044
450,441
485,471
300,935
38,332
0
20,436
20,436038,332300,935485,471450,441524,044764,840681,365
       Short Long Term Debt 
681,365
764,840
780,456
655,123
543,594
319,165
319,165
0
0
00319,165319,165543,594655,123780,456764,840681,365
       Accounts payable 
665,100
453,082
303,771
270,424
434,164
440,146
512,426
0
0
00512,426440,146434,164270,424303,771453,082665,100
       Other Current Liabilities 
74,750
76,308
51,591
36,297
55,234
43,211
69,295
0
0
0069,29543,21155,23436,29751,59176,30874,750
   > Long-term Liabilities 
0
0
0
301,058
177,558
109,457
109,489
0
0
00109,489109,457177,558301,058000
       Long term Debt Total 
0
0
194,353
123,836
69,269
16,921
8,489
1,445
0
01,4458,48916,92169,269123,836194,35300
       Long-term Liabilities Other 
0
0
0
34,619
0
0
0
0
0
0000034,619000
> Total Stockholder Equity
988,124
1,113,112
1,435,751
1,923,849
2,242,180
2,693,446
3,130,889
3,752,920
4,328,775
4,328,7753,752,9203,130,8892,693,4462,242,1801,923,8491,435,7511,113,112988,124
   Common Stock
163,108
163,108
163,108
200,000
200,000
200,000
200,000
200,000
200,297
200,297200,000200,000200,000200,000200,000163,108163,108163,108
   Retained Earnings 
440,972
565,960
1,272,643
1,723,849
2,042,180
2,493,446
2,930,889
2,909,843
4,128,478
4,128,4782,909,8432,930,8892,493,4462,042,1801,723,8491,272,643565,960440,972
   Capital Surplus 
0
0
0
0
0
646,166
646,166
646,166
0
0646,166646,166646,16600000
   Treasury Stock000000000
   Other Stockholders Equity 
3,500
3,500
79,129
3,500
4,498
4,830
215
-3,089
0
0-3,0892154,8304,4983,50079,1293,5003,500



Balance Sheet

Currency in INR. All numbers in thousands.




Cash Flow

Currency in INR. All numbers in thousands.




Income Statement

Currency in INR. All numbers in thousands.


Latest Income Statement (annual, 2022-03-31)

Gross Profit (+$)
totalRevenue4,721,233
Cost of Revenue-2,185,816
Gross Profit2,535,4172,535,417
 
Operating Income (+$)
Gross Profit2,535,417
Operating Expense--
Operating Income873,9302,535,417
 
Operating Expense (+$)
Research Development-
Selling General Administrative704,689
Selling And Marketing Expenses-
Operating Expense-704,689
 
Net Interest Income (+$)
Interest Income14,512
Interest Expense--
Net Interest Income-14,512
 
Pretax Income (+$)
Operating Income873,930
Net Interest Income-
Other Non-Operating Income Expenses-
Income Before Tax (EBT)959,396873,930
EBIT - interestExpense = 0
693,553
693,553
Interest Expense-
Earnings Before Interest and Taxes (ebit)-959,396
Earnings Before Interest and Taxes (ebitda)-
 
After tax Income (+$)
Income Before Tax959,396
Tax Provision-265,843
Net Income From Continuing Ops-693,553
Net Income693,553
Net Income Applicable To Common Shares693,552
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-0
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
LIVE.CC
1 minute ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of LIVE.CC.

LIVE.CC Daily Candlestick Chart
LITION.CC
1 minute ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of LITION.CC.

LITION.CC Daily Candlestick Chart
LIT.CC
1 minute ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of LIT.CC.

LIT.CC Daily Candlestick Chart
LCC.CC
3 minutes ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of LCC.CC.

LCC.CC Daily Candlestick Chart
LAYER.CC
4 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of LAYER.CC.

LAYER.CC Daily Candlestick Chart
LANA.CC
4 minutes ago

I found you a MACD Bullish Reversal Divergence on the daily chart of LANA.CC.

LANA.CC Daily Candlestick Chart
KLV.CC
7 minutes ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of KLV.CC.

KLV.CC Daily Candlestick Chart
KIT.CC
7 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of KIT.CC.

KIT.CC Daily Candlestick Chart
KLAY.CC
7 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of KLAY.CC.

KLAY.CC Daily Candlestick Chart
KGC.CC
7 minutes ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of KGC.CC.

KGC.CC Daily Candlestick Chart
KDAG.CC
8 minutes ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of KDAG.CC.

KDAG.CC Daily Candlestick Chart
KAVA.CC
8 minutes ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of KAVA.CC.

KAVA.CC Daily Candlestick Chart
JEWEL.CC
10 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of JEWEL.CC.

JEWEL.CC Daily Candlestick Chart
JAR.CC
10 minutes ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of JAR.CC.

JAR.CC Daily Candlestick Chart
JADE.CC
11 minutes ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of JADE.CC.

JADE.CC Daily Candlestick Chart
IRIS.CC
11 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of IRIS.CC.

IRIS.CC Daily Candlestick Chart
IPL.CC
12 minutes ago

I found you a RSI Bearish Reversal Divergence on the daily chart of IPL.CC.

IPL.CC Daily Candlestick Chart
IOTX.CC
13 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of IOTX.CC.

IOTX.CC Daily Candlestick Chart
IMT.CC
14 minutes ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of IMT.CC.

IMT.CC Daily Candlestick Chart
IDEA.CC
16 minutes ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of IDEA.CC.

IDEA.CC Daily Candlestick Chart
IBP.CC
17 minutes ago

I found you a MACD Bearish Hidden Divergence on the daily chart of IBP.CC.

IBP.CC Daily Candlestick Chart
HVN.CC
18 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of HVN.CC.

HVN.CC Daily Candlestick Chart
HUNT.CC
18 minutes ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of HUNT.CC.

HUNT.CC Daily Candlestick Chart
HTDF.CC
19 minutes ago

I found you a MACD Bullish Hidden Divergence on the daily chart of HTDF.CC.

HTDF.CC Daily Candlestick Chart
HPS.CC
20 minutes ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of HPS.CC.

HPS.CC Daily Candlestick Chart